New Search

If you are not happy with the results below please do another search

1121 search results for:

491

CardiNor enter into a distribution agreement with Demeditec Diagnostics GmbH for the CE marked CardiNor Secretoneurin ELISA test

Cardiovascular DX company CardiNor AS today announces that it has signed an exclusive agreement with Demeditec for sales of the CE marked CardiNor Secretoneurin ELISA test in Germany. In addition, the agreement gives Demeditec the right to sell the test, on non-exclusive basis, in 15 countries outside Europe which includes India, South Korea, Mexico and […]

492

Agilent opens Customer Experience Center highlighting genomics and diagnostics solutions

Agilent Technologies has opened a new Customer Experience Center (CEC) in Lexington, Massachusetts, U.S., focused on solutions from Agilent genomics and diagnostics product portfolios. The facility will serve as a regional hub for Agilent representatives to showcase and demonstrate both product capabilities and complete workflow solutions to customers.

493

Role of AI in optimizing the whole-slide image acquisition workflow

By Dr Maria Ada Prusicki Advances in whole-slide scanning technology enabled the automation of microscopy. Researchers can run image acquisition overnight and check the results remotely, minimizing the need for supervision and optimizing their use of time. Nonetheless, a few steps still require intense human supervision, especially for sample identification and scan area definition, where […]

494

Antibody tests in the management and follow-up of coeliac disease

by Dr Jacqueline Gosink In 2022, the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published a position paper on the management and follow-up of children and adolescents with coeliac disease (CD), following publication of new guidelines for the diagnosis of CD in 2020. This article discusses the different markers that can be used […]

496

Therapeutic drug monitoring for vancomycin: past, present and future

Nicole M. Ondrush, PharmD, AAHIVP ; Bryan T. Mogle, PharmD, BCPS Vancomycin remains a mainstay of treatment for invasive infections caused by methicillin-resistant Staphylococcus aureus, and requires therapeutic drug monitoring (TDM) for optimal drug delivery. Herein, we discuss various methods of performing TDM for vancomycin, challenges associated with each method, and future directions for vancomycin […]

497

The Newborn Genomes Programme: early diagnosis of rare genetic diseases

There are estimated to be more than 7000 rare genetic diseases (RGDs), which are defined as affecting less than 1 in 2000 people in Europe, many of which are monogenic. Although rare individually, collectively they affect 1 in 50 individuals. Diagnosis of these diseases is often very difficult and patients can remain undiagnosed or diagnosis […]

500

CardiNor enter into a distribution agreement with Demeditec Diagnostics GmbH for the CE marked CardiNor Secretoneurin ELISA test

Cardiovascular DX company CardiNor AS today announces that it has signed an exclusive agreement with Demeditec for sales of the CE marked CardiNor Secretoneurin ELISA test in Germany. In addition, the agreement gives Demeditec the right to sell the test, on non-exclusive basis, in 15 countries outside Europe which includes India, South Korea, Mexico and […]